Souhaitez-vous accéder aux communiqués récents ?

Austin, TX, USA, July 02, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neonatal Infant Care Market Size, Trends and Insights By Product Type...

Austin, TX, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Neonatal Infant Care Market Size, Trends and Insights By Product Type...

Austin, TX, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Neonatal Intensive Care Respiratory Devices Market Size, Trends and Insights By...

Data shows transvenous phrenic nerve stimulation reduces lung collapse and significantly increases availability of lungs that meet transplant criteria

Kither Biotech announces the successful completion of its Phase 1 clinical study of KIT2014 in healthy participants.

– Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the Asthma Control Questionnaire-6 (ACQ-6) in participants with CRSwNP and...

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...

Austin, TX, USA, April 08, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Anesthesia and Respiratory Devices Market Size, Trends and Insights By Product...

TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...

Results in a population of 278 patients affirm statistically significant mortality reductionsBenefits observed across severity groups and in subjects with serious comorbiditiesCompany files...